Details of the Drug Reposition

General Information of This Drug (ID: DMXG9ES)

Drug Name
RXI-109   DMXG9ES
Synonyms A45sd-RxNA
Drug Type
Small interfering RNA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hypertrophic scars DISE6R2O EE60 Phase 2 [1]
Fibrosis DIS6FM27 GA14-GC01 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02246465) A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars. U.S. National Institutes of Health.